Cibus, Inc. logo

CBUS Earnings Date: Nov 12, 2026 (Estimated) — Cibus, Inc.

NASDAQ · Healthcare · Biotechnology

Updated

Price $1.33
Market Cap $101.7M
P/E -0.8
52W Range $1.09 – $4.19
Next Earnings · After close (est.)

When is CBUS's next earnings date?

Cibus, Inc. (CBUS) is expected to report Q3 2026 earnings on Thursday, November 12, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.20 on revenue of $1.3M.

How did CBUS do in its last earnings report?

In its most recent report on Aug 13, 2026 (Q2 2026), Cibus, Inc. posted EPS of -$0.29 versus the -$0.19 estimate, a miss of 45.0%. Revenue was $994,000 against a $1.7M estimate. The stock's 1-day post-earnings move was -6.8%.

How much does CBUS stock move after earnings?

CBUS beat EPS estimates in 2 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 10.1% (up or down) in the day after earnings.

About Cibus, Inc.

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-13Q2 2026-0.19-0.29-45.00%$994,000❌ Miss-6.84%-10.00%-21.58%
2026-05-14Q1 2026-0.16-0.33-106.25%$1.7M❌ Miss-7.09%-2.13%-9.93%
2026-03-17Q4 2025-0.26-0.42-61.54%$1.1M❌ Miss-24.73%-26.36%-61.14%
2025-11-13Q3 2025-0.27-0.44-62.96%$615,000❌ Miss-2.40%+0.80%+21.60%
2025-08-14Q2 2025-0.47-0.61-29.79%$933,000❌ Miss-4.08%-14.97%-6.80%
2025-03-20Q4 2024-0.76-0.87-14.47%$1.2M❌ Miss-6.39%-6.85%-17.81%
2024-11-07Q3 2024-0.890.06+106.74%$1.7M✅ Beat+19.89%+8.64%+2.05%
2024-03-21Q4 2023-1.43-1.27+11.19%$1.1M✅ Beat+9.10%+20.24%-14.35%

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .